Given the high suspicion, genetic testing for a panel of cancer susceptibility genes (ATM, PALB2, CDH1, CHEK2, NBN, PTEN, STK11, TP53, BRIP1, MSH2, MLH1, MSH6, PMS2, EPCAM, RAD51C, RAD51D, APC) was subsequently proposed. Here, RAD51D is linked to cancer.